Fens MH - Search Results

1

Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.

Ruijgrok EJ, Fens MH, Bakker-Woudenberg IA, van Etten EW, Vulto AG. Ruijgrok EJ, et al. Among authors: fens mh. Antimicrob Agents Chemother. 2006 May;50(5):1852-4. doi: 10.1128/AAC.50.5.1852-1854.2006. Antimicrob Agents Chemother. 2006. PMID: 16641459 Free PMC article.

2

Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response.

Becker MJ, de Marie S, Fens MH, Hop WC, Verbrugh HA, Bakker-Woudenberg IA. Becker MJ, et al. Among authors: fens mh. J Antimicrob Chemother. 2002 May;49(5):813-20. doi: 10.1093/jac/dkf010. J Antimicrob Chemother. 2002. PMID: 12003976 Free article.

3

Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis.

Becker MJ, de Marie S, Fens MH, Verbrugh HA, Bakker-Woudenberg IA. Becker MJ, et al. Among authors: fens mh. J Antimicrob Chemother. 2003 Sep;52(3):428-34. doi: 10.1093/jac/dkg367. Epub 2003 Aug 13. J Antimicrob Chemother. 2003. PMID: 12917249

4

Scintigraphic imaging using 99mTc-labeled PEG liposomes allows early detection of experimental invasive pulmonary aspergillosis in neutropenic rats.

Becker MJ, Dams ET, de Marie S, Oyen WJ, Boerman OC, Fens MH, Verbrugh HA, Bakker-Woudenberg IA. Becker MJ, et al. Among authors: fens mh. Nucl Med Biol. 2002 Feb;29(2):177-84. doi: 10.1016/s0969-8051(01)00291-8. Nucl Med Biol. 2002. PMID: 11823122

5

Pathophysiology of unilateral pulmonary aspergillosis in an experimental rat model.

Becker MJ, De Marie S, Fens MH, Haitsma JJ, Verbrugh HA, Lachmann B, Bakker-Woudenberg IA. Becker MJ, et al. Among authors: fens mh. Med Mycol. 2006 Mar;44(2):133-9. doi: 10.1080/13693780500271749. Med Mycol. 2006. PMID: 16519016

6

Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma.

Fens MH, Hill KJ, Issa J, Ashton SE, Westwood FR, Blakey DC, Storm G, Ryan AJ, Schiffelers RM. Fens MH, et al. Br J Cancer. 2008 Oct 21;99(8):1256-64. doi: 10.1038/sj.bjc.6604675. Epub 2008 Sep 16. Br J Cancer. 2008. PMID: 18797467 Free PMC article.

7

Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.

Banciu M, Schiffelers RM, Fens MH, Metselaar JM, Storm G. Banciu M, et al. Among authors: fens mh. J Control Release. 2006 Jun 12;113(1):1-8. doi: 10.1016/j.jconrel.2006.03.019. Epub 2006 Apr 7. J Control Release. 2006. PMID: 16707187

8

Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement.

Estapé Senti M, de Jongh CA, Dijkxhoorn K, Verhoef JJF, Szebeni J, Storm G, Hack CE, Schiffelers RM, Fens MH, Boross P. Estapé Senti M, et al. Among authors: fens mh. J Control Release. 2022 Jan;341:475-486. doi: 10.1016/j.jconrel.2021.11.042. Epub 2021 Dec 7. J Control Release. 2022. PMID: 34890719 Free article.

9

Liposomal targeting of angiogenic vasculature.

Schiffelers RM, Fens MH, Janssen AP, Molema G, Storm G. Schiffelers RM, et al. Among authors: fens mh. Curr Drug Deliv. 2005 Oct;2(4):363-8. doi: 10.2174/156720105774370186. Curr Drug Deliv. 2005. PMID: 16305439 Review.

10

Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice.

Banciu M, Fens MH, Storm G, Schiffelers RM. Banciu M, et al. Among authors: fens mh. J Control Release. 2008 Apr 21;127(2):131-6. doi: 10.1016/j.jconrel.2008.01.008. Epub 2008 Jan 30. J Control Release. 2008. PMID: 18291548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters